Day 1

08:15 AM

CHAIRPERSON’S OPENING REMARKS

Jody Ranck, DrPH, CEO, Krysalis Labs & Executive Vice President of Strategy, Ram Group 

08:20 AM

KEYNOTE ADDRESS: LAY-OF-THE-LAND FOR 21ST CENTURY BUSINESS MODELS: HIERARCHIES, PLATFORMS, CRYPTONETWORKS

As we transition from an industrial to a knowledge economy, the possible range of business models and strategies has never been broader. This presentation will present an organizing framework to understand the continuum of centralization/decentralization options:
  • CENTRALIZED: Industrial model hierarchies -- traditional corporations and governments
  • PARTIALLY DECENTRALIZED: Web 2.0 platforms
  • DECENTRALIZED: Web 3.0 distributed cryptonetworks
Questions addressed about the organizing framework and model options will include:
  • What is decentralization and why is it such a big deal?
  • What are defining characteristics and tradeoffs among the 3 models?
  • How/where is value created?
  • How is value captured and distributed?
  • What are implications for various healthcare stakeholders: patients, providers, payers, supply chain participants, etc. The presentation will highlight the unique roles that blockchains can play in different business models.
Vince Kuraitis JD, MBA, Principal, Better Health Technologies, LLC

08:50 AM

KEYNOTE ADDRESS: SOME THESES ON DECENTRALIZATION, PLATFORMS AND CRYPTOECONOMICS IN HEALTHCARE

The blockchain arena is dominated by the call for radical decentralization of technologies and business models or services. Much of this is driven by the underlying politics that led to the original innovation of Bitcoin. In healthcare we need to take a more circumspect approach and ask what is decentralized and for whom? The great public secret of health IT is that the dominant companies in the ecosystem are founded on centralized business models of data capture. The major platforms in our economy are coming under criticism for being too powerful and represent a danger to our privacy and security. Meanwhile, 2017 saw the growth in ICOs that have been represented as a means to democratize financing. In reality, the current models, based on flawed understandings of tokenization and cryptoeconomics, do little to build sustainable, patient-driven new business models. This keynote will raise these issues as problems the healthcare and blockchain community must confront in moving the field forward in the coming years.
Jody Ranck, DrPH, CEO, Krysalis Labs & Executive Vice President of Strategy, Ram Group 

09:15 AM

KEYNOTE ADDRESS: THE MARKETPLACE BUSINESS MODEL IN HEALTHCARE

  • Healthcare’s current state
  • The opportunity for blockchain
  • Opportunities and challenges in healthcare use case development
  • B2B vs B2C
  • Technical models, business models, governance structures
  • Q&A
Opportunities for improving our care delivery system remain locked inside protected, volume-focused pipeline business models and silo'd interests.  The opportunity for blockchain is to change the current paradigm from the inside out or flank it altogether.  This session will review the various approaches to healthcare blockchain use cases over the past two years. Topics will include a discussion of why use cases are plentiful, but meaningful use will require a sophisticated approach that includes the correct technical solution, business model innovation, and new governance concepts.
John Bass, Founder & CEO, Hashed Health  

10:15 AM

PANEL DISCUSSION: ACCELERATING CHANGE IN THE HEALTHCARE BLOCKCHAIN ECOSYSTEM

  • Legal/regulatory issues
  • The role of consortia
  • Blockchain implementation platforms and standards
Moderator:
Thomas P. Gross, MS, JD, Attorney & Member, Adjunct Faculty, The George Washington University Graduate Business School
Panelists:
John Bass, Founder & CEO, Hashed Health
Doug Bulleit, Executive Director, The FHIRBlocks Project
Donna Houlne  BSN, MHA, MHRM, US Healthcare Leader, Global Business Services, IBM
Susan Ramonat, Founder & CEO, Spiritus Partners

11:15 AM

PANEL DISCUSSION: BLOCKCHAIN’S POTENTIAL ROLE IN PROVIDER-PAYER COLLABORATION

The United States healthcare systems administrative cost burden is nearly three times that of other developed countries representing $240B/yr. The leading cost driver for this difference is the multi-payer environment that exists in the US, wherein each payer has its own rules, reporting measures, reimbursement models, etc. that provider organizations must respond to. Today, few of the administrative tasks between providers and payers are automated. As the industry moves to more value-based reimbursement models, the potential reporting burden and associated administrative costs will only accelerate.

But this need not be the case in the future. The promised combination of Blockchain, smart contracts, artificial intelligence and machine learning algorithms can significantly automate many of these administrative processes and tasks. This session will explore where the most promising near-term opportunities lie as well as long-term, what we may envision as a healthcare system of the future.
Moderator:
John Moore, Founder & Managing Partner, Chilmark Research
Panelists:
Kyle Culver, Solution Architect, Humana
John D. Halamka, MD, MS, Chief Information Officer, Beth Israel Deaconess Medical Center & Chief Information Officer and Dean for Technology, Harvard Medical School

12:00 PM

01:00 PM

KEYNOTE ADDRESS: TECHNOLOGICAL OPPORTUNITY, BUBBLES AND INNOVATION: THE DYNAMICS OF INITIAL COIN OFFERINGS

Using unique data on over 1,000 crypto tokens, we provide the first, comprehensive exploration of the phenomenon of Initial Coin Offerings (ICOs). ICOs are increasingly used by entrepreneurs, open source teams, and established players in the blockchain space to raise capital, attract developers to an ecosystem, crowdsource key resources, and encourage usage by early adopters. After exploring the economics of token sales and blockchain technology, we present novel data on the characteristics of different tokens, the teams behind them, their evolution and performance. Our findings highlight that contrary to common belief, while many ICOs are launched by teams across the globe, a disproportionate share of capital still flows to traditional entrepreneurial hubs. Investors, instead, are more geographically dispersed. By focusing on founders and their skills, the codebases they maintain, and information contained in their white papers, we further separate high potential projects from lower quality ones.
Christian Catalini, PhD, Fred Kayne (1960) Career Development Professor of Entrepreneurship & Assistant Professor of Technological Innovation, Entrepreneurship, and Strategic Management, MIT Sloan School of Management

01:30 PM

PANEL DISCUSSION: TOKEN OFFERINGS AND FINANCING OF BLOCKCHAIN STARTUPS AND INITIATIVES

  • Token taxonomy
  • Regulatory environment for tokens
    • SEC DAO report July 2017
    • SEC compliant token offerings (Reg S, Reg D, Reg A, etc.)
    • Tokens regulated as commodities
    • Tokens regulated through money transmission laws (FinCen)
    • State regulatory issues
  • There are currently are 120+ healthcare token offerings. How would you characterize these?
  • Impact of token offerings on healthcare
  • Which among healthcare token offerings do you see as either getting early traction or having the potential for early traction? What are they doing right?
  • What are some of the biggest mistakes that you're seeing healthcare token issuers make?
Moderator:
Alan Gilbert, MPA, FHIMSS, Chief Growth Officer, V3 Health Strategy
Panelists:
Michael Dillhyon, Founder, healthbank
Michelle Gitlitz, Partner, Blank Rome LLP
Katherine Kuzmeskas, MPH, Founder & CEO, SimplyVital Health
Robert Miller, Director of Business Development, Medicalchain
Adi Segal, CoFounder & CEO, SeeThru

02:30 PM

ENGAGING AND INCENTIVIZING HEALTHCARE STAKEHOLDERS TOWARD SUSTAINABLE VALUE USING BLOCKCHAIN

Well-established episode of care examples exist in which the concerted effort of stakeholder engagement, from providers to patient, has provided sustainable clinical and cost-effective benefits. Specific examples include post-operative PT; opioid management; chronic diseases such as diabetes, hypertension etc. Nonetheless, even such episode-driven efforts are vulnerable to the threat of multi-stakeholder “inconsistencies.” Within this context, sustainable (and scalable) operational achievement of value from these and other episode-of- care efforts underscores the reliance on a standardized/consistent, objective goal-defined, and feedback/ reinforcing stakeholder engagement platform. Our proposal is that a ‘Smartcare Contracts’ platform built using Blockchain technology will function to engage the critical stakeholders that represent the value chain components of standardized, consensus-/evidence- based clinical episode-driven outcomes. In addition to breaking the data silos that exist in healthcare today,Blockchain technology promises value creation by engaging stakeholders across care delivery and incentivizes stakeholders by automatically distributing the value through smart contracts.
Methods:
  • We provide examples of established, evidence-based episodes of care e.g. post-surgical length-of- stay (LOS), post-surgical re- hospitalization, avoidable hospitalization for cancer patients on chemo, etc.
  • Draw out the stakeholder relationships involved in each Smartcare Contract
  • List out the objectives of each Contract e.g. time-based goals, medication discontinuation goals, etc.
  • List out the incentives for each stakeholder to comply and aim for the above objective goals
Srikanth Challa, Senior Director of Blockchain, Infosys
Aymen Elfiky, MD, MSc, MBA, Instructor, Medical Oncology, Dana-Farber Cancer Institute & Instructor, Medicine, Harvard Medical School

03:30 PM

PANEL DISCUSSION: BLOCKCHAIN INNOVATION FOR HEALTHCARE SERVICES

Blockchain capabilities, such as transaction record immutability, mean little for healthcare except in the context of changes in how services are delivered and how complex patient conditions can be treated over time. On the panel are healthcare innovators who are using blockchain to address specific challenges in healthcare data access, service delivery, and patient engagement. The panel will showcase innovative solutions in health data access, patient connection to providers and communities, service integration, and health system interoperability in a distributed environment.
Moderator:
Neil Wasserman, PhD, Managing Partner, Timewave Analytics & Adjunct Professor, Computer Science, George Washington University
Panelists:
Lorraine Frias, Senior Director of Strategic Initiatives – Blockchain, Advanced Technology Collaborative, Optum
Dr. Gordon Jones, President & COO, Universal Health Coin

Katherine Kuzmeskas, MPH, Founder & CEO, SimplyVital Health
Stuart Lackey, Co-Founder & CEO, Solaster
Gary Meyer, AVP, Cognizant
Paul Viskovich, Founder & CEO, Optima Curis Inc.


04:45 PM

IMPROVING PROVIDER DATA ACCURACY: A COLLABORATIVE APPROACH USING A PERMISSIONED BLOCKCHAIN

Billions of dollars are spent annually on provider data management, yet provider directories often contain inaccuracies that dramatically increase the cost of care while reducing its quality. This session will provide an overview of why Humana, MultiPlan, Optum, Quest Diagnostics and UnitedHealthcare have formed an alliance to explore the use of blockchain technology in tackling the challenge of accurate and efficient provider data management and sharing. It will highlight the current challenges and state of provider data exchange and the goals and approach of the initial pilot project for the alliance. Learning Objectives:
  1. Define the current state of provider data exchange
  2. Evaluate the use of blockchain technology to address healthcare challenges
  3. Explore how health care organizations can work working together to leverage blockchain technology to provide more effective patient care
Jason O’Meara, Director of Enterprise Information Management, Quest Diagnostics Enterprise Architecture and Design

05:15 PM

BLOCKCHAIN FOR HEALTH SCIENCE RESEARCH

This session will give an overview of the opportunities for blockchain to improve health science research and advance evidence-based clinical practice. It will give an overview of potential applications from basic science to clinical research to meta-analysis with a focus on how blockchain can reduce the 17 years it takes to go from “bench to bedside” giving us better science, cheaper research, and faster miracles. It will touch briefly on impact in areas including administrative grant review, regulatory review, reproducibility challenges and solutions, peer-review and publications, and meta-analysis. It will cover some of the key efforts in the current blockchain health science ecosystem. It will also provide an in-depth real-world example of meta-analysis opportunity that can expanded with the Federal Interagency Traumatic Brain Injury Research registry (FITBIR; https://fitbir.nih.gov/). This session will serve as a primer for a more in-depth look at multi-site clinical research trials and associated regulatory challenges that blockchain can resolve for clinical researchers in the following session.
Sean T. Manion, PhD, CEO, Science Distributed

05:35 PM

BARRIERS TO ADOPTION AND THE PATH FORWARD FOR BLOCKCHAIN IN CLINICAL RESEARCH AND HEALTHCARE DELIVERY

This session will describe barriers to adoption of blockchain and related technologies in clinical and translational research and evidence-based healthcare delivery, surveying blockchain challenge-areas including on- and off-chain governance, standards, regulation, mutualized ownership, capital formation, cross-chain interoperability, and more.  The role of IRBs in multi-site clinical research and NIH's SMART IRB initiative will be highlighted along with the challenges of evolving pre-blockchain trust models that inform relationships between investigators, subjects, sites, public and private sector sponsors, CROs, peer-reviewed journals, IRBs, and regulators.  Places broader adoption of blockchain technology in research and healthcare delivery in context of its dynamic oversight and regulatory framework, including potential disruption of IRBs and the GDPR's recent entry into force.
Heather Flannery, CEO, Obesity PPM
Day 2

07:15 AM

07:45 AM

CHAIRPERSON’S OPENING REMARKS

Jody Ranck, DrPH, CEO, Krysalis Labs & Executive Vice President of Strategy, Ram Group 

08:00 AM

PANEL DISCUSSION: BLOCKCHAIN, AI & MACHINE LEARNING

Advancements in the family of technologies referred to as "artificial intelligence" or AI continue to accelerate and deliver breakthroughs in healthcare, with recent examples in radiology, ophthalmology, and diabetes management filling headlines. This panel will introduce and explore AI methods such as machine learning, deep learning, and robotic process automation and its convergence with blockchain and distributed ledger technology. We'll look at how blockchain can be used to more rapidly assemble the very large data sets needed to successfully train AIs, the role of smart contracts in this process, the mechanics of off-chain big data storage, and the critical role that auditable data provenance plays in manifesting ethical, transparent AI inferences and conclusions.
Moderator:
Heather Flannery, CEO, Obesity PPM
Panelists:
Roger Boodoo, MD, Co-Founder, Diagnosis Protocol & Clinical Informatics Fellow, University of Illinois Hospital and Health Sciences System
Dr. Paul A. Markham, MBA, President, V3 Health Strategy
Tom Woolf, PhD, Professor, Johns Hopkins University Department of Physiology and Department of Computer Science & CEO, DaiWare, Inc.

08:45 AM

PANEL DISCUSSION: BLOCKCHAIN PRIVACY, SECURITY, AND COMPLIANCE

Leveraging theory and experience, we will explore the disruptive impact of Blockchain on privacy and data security in the context of an evolving regulatory environment around the world. We will do it through the lens of the ‘Blockchain Triad’: disintermediated business model, decentralized operational model, and technology patterns that are needed to support both. In the interest of enriching the conversation, we will engage the audience in a critical examination of what Healthcare means today and going forward, and how it may influence our perspectives.
Moderator:
Ron Ribitzky, MD, Founder/CEO, R&D Ribitzky
Panelists:
Adrian Gropper, MD, CTO, Patient Privacy Rights
Christine Ferrusi Ross, Independent Product Development and Marketing Consultant
Tom Woolf, PhD, Professor, Johns Hopkins University Department of Physiology and Department of Computer Science & CEO, DaiWare, Inc.

09:30 AM

PANEL DISCUSSION: BLOCKCHAIN & HEALTHCARE DATA MANAGEMENT

  • Blockchain is potentially a way that medical records can be shared at the direction of patients. It has the advantage of not requiring the involvement of healthcare provider office staff every time a patient requests a release of records. How do you expect that patient consents to release records available through a blockchain will work?
  • Information to healthcare data can be stored directly on a blockchain. Alternatively, links to data stored elsewhere can be recorded on a blockchain. What healthcare information is best to store on the blockchain and what is best stored off the blockchain?
  • For a blockchain to be an effective way to share healthcare information, standardized data models will be needed. How to you see such models being adopted? Will metadata play a significant role in making shared data accessible?
  • Identifying patients by social security number is a common practice. Though rare, it sometimes happens that two people are issued the same social security number. The likelihood of two such people being patients of the same healthcare provider is extremely low. This allows manual interventions to keep the records of two such patients distinct. If medical records are stored on a blockchain in a fully automated way, then how would you propose to uniquely identify patients?
  • HIPAA requires personal health records to be confidential for 50 years after the patient’s death. Will this pose a problem for the confidentiality of records on a blockchain?
  • Occasionally, erroneous information is recorded in a medical record. If incorrect information gets into a blockchain-based medical record, what mechanism should be available to correct it and who should be able to provide corrections? How will this mechanism cope with medical identity theft?
Moderator:
Mark Grand, Senior Director (Digital & Analytics), HCL Technologies Ltd.
Panelists:
Evin McMullen, Product & Operations, Linnia, Consensys
Ricky Sahu, Co-Founder & CEO, 1upHealth
Benjamin D. Schanker, MD, MBA, MPH, CEO & Co-Founder, Wholesome Inc. 
Raj Sharma, CEO, Health Wizz

10:45 AM

PANEL DISCUSSION: BLOCKCHAIN APPLICATIONS FOR PHARMA

  • Broadly, where is blockchain being integrated into the Pharmaceutical / Biotech industries?
  • What are the key advantages in leveraging blockchain and smart contracts for biopharmas?  What are the advantages of linear vs. multidimensional blockchain?
  • What does blockchain add to organizations?
  • What are the current barriers to entry themes for biopharmas?  How are companies navigating those challenges?
  • What security challenges are Pharma & Biotech companies facing as it relates to patient, safety, clinical, and operational data?
  • From an execution standpoint - are companies taking an enterprise-driven or issues-driven approach to integrating blockchain into their organizations?
  • Where have the panelists seen the most success both in short and long term?
  • Are organizations relying on a ground-up development strategy or “turnkey”?
  • How are organizations approaching the development of blockchain capabilities?  Do they have existing teams equipped with the right level of technical acumen to oversee any external vendors?
  • Relevant Examples: Pricing / Contracting, Patient Owned Data, Claims processing - minimizing redundancies, Records keeping // sunshine act // JSOX
Moderator:
Brian Slizgi, Director, Pharmaceutical & Life Sciences R&D Advisory, PwC
Panelists:
Ajay Ahuja, MD, MBA, CEO, Nexus
Scott Bischoff, Director of Marketing, Nexus
Dany De Grave, Founder, Unconventional Innovation

11:45 AM

FIRESIDE CHAT WITH DR. GARY GOTTLIEB OF PARTNERS IN HEALTH

Gary L. Gottlieb, MD, MBA, Chief Executive Officer, Partners In Health & Professor of Psychiatry, Harvard Medical School
Neil Wasserman, PhD, Managing Partner, Timewave Analytics & Adjunct Professor, Computer Science, George Washington University

12:05 PM

PANEL DISCUSSION: BLOCKCHAIN IMPACT ON GLOBAL HEALTH

The power of innovative platforms that take advantage of blockchain capabilities will be fully realized in the context of global deployment. Both in terms of business opportunity and the potential for impact on population health, global distribution of blockchain applications will multiply the value of locally produced innovation. The panel will address opportunities that derive from patient identity, supply chain tracking for medicines and services, and improved capabilities to track health status, environmental conditions, nutrition, and other factors that affect population health on a global scale. The discussion will also identify obstacles that may impede the implementation of blockchain applications such as lack of standards, limited technical infrastructure, and a variance in administrative capabilities to support health systems and service operations.
Moderator:
Neil Wasserman, PhD, Managing Partner, Timewave Analytics & Adjunct Professor, Computer Science, George Washington University
Panlists:
Michael Dillhyon, Founder, healthbank
Gary L. Gottlieb, MD, MBA, Chief Executive Officer, Partners In Health & Professor of Psychiatry, Harvard Medical School
Jody Ranck, DrPH, CEO, Krysalis Labs & Executive Vice President of Strategy, Ram Group

12:30 PM

SOLVING A BLOCKCHAIN USE CASE FOR ENTERPRISE SOFTWARE IN HEALTHCARE

  • Why Blockchain & Use Cases Evaluated
  • Current Use Case Developed – description, reasons, value, applicability
  • Evaluation Process – platforms reviewed, pros/cons; tools required, skillset; infrastructure
  • Challenges – e.g., documentation limitation; versions changing quickly, etc.
  • Lessons Learned to Date
Nick Larocca, CIO & Co-Founder, Acero Health Technologies

12:55 PM

CHAIRPERSON’S CONCLUDING REMARKS

Jody Ranck, DrPH, CEO, Krysalis Labs & Executive Vice President of Strategy, Ram Group 

02:00 PM

OPTIONAL POST-SUMMIT WORKSHOP – PLATFORM PILOT DESIGN FOR BLOCKCHAIN-BASED HEALTHCARE SERVICES

Workshop Hours: 2:00 pm to 5:30 pm
Workshop Chairperson:
Neil Wasserman, PhD, Managing Partner, Timewave Analytics & Adjunct Professor, Computer Science, George Washington University
Workshop Instructors:
Kyle Culver, Solution Architect, Humana
Lorraine Frias, Senior Director of Strategic Initiatives – Blockchain, Advanced Technology Collaborative, Optum
Vince Kuraitis JD, MBA, Principal, Better Health Technologies, LLC
Evin McMullen, Product & Operations, Linnia, Consensys
Gary Meyer, AVP, Cognizant

Building on the concepts developed during the first 1 1/2 days of the Summit, the Platform Pilot Design Workshop will focus on actual development of use cases that create value in a platform ecosystem. The use case forms a basis for pilot definition and deployment. The workshop will present and apply tools for platform analysis and use case development from both technical and business perspectives.  The participants will form groups focused on specific business domains to produce use cases, which take advantage of the unique attributes of platform models and blockchain capabilities. The use cases will address key challenges in healthcare such as patient identity, supply chain management, payment and incentive systems, population health, care coordination, health records access, or other areas of business interest to the participants. The workshop will follow a structured process to identify opportunities in health systems that are amenable to a blockchain-based platform approach. The workshop participants will map the agents in these ecosystems and address a number of key questions to test the viability of a blockchain platform business model in these domains. The aim is for the workshop participants to produce a detailed design for a blockchain-enabled pilot application and a platform strategy to deliver measurable business and healthcare outcomes in a real healthcare business environment.